New(ish) Drug for MACE Prevention

from Primary Care Pod · host Dr. Mark List

Bempedoic Acid aka Nexletol has a new trial in NEJM that shows MACE reduction in very high risk patients (mostly secondary but some primary prevention). NNT? NNH? Other trials on Bempedoic acid? Tune in and find out.

Episode metadata supplied by the publisher feed · Published Mar 5, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

New(ish) Drug for MACE Prevention

0:00 15:30

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Primary Care Pod?

This episode is 15 minutes long.

When was this Primary Care Pod episode published?

This episode was published on March 5, 2023.

Can I download this Primary Care Pod episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!